The Impact of DAAs on Transplant Costs and Outcomes The Impact of DAAs on Transplant Costs and Outcomes
A new study provides insight into the costs of HCV treatment in liver and kidney transplant recipients and the impact of these agents on longer-term transplant outcomes.American Journal of Transplantation
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Transplantation Journal Article Source Type: news
More News: Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology